Latest NCI-designated Cancer Center Stories
ALBANY, N.Y., Jan. 31, 2013 /PRNewswire/ -- Governor Cuomo announced yesterday that a strategic biotechnology project in Western New York, initially funded through the Regional Economic Development Councils, is expanding successfully, leveraging additional private investments for further growth and strengthening the regional economy. The Center for Personalized Medicine (CPM), an extension of Roswell Park Cancer Institute (RPCI), has leveraged $18.5 million in additional investments...
CLEVELAND, Jan. 23, 2013 /PRNewswire/ -- A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spread of breast cancer. Published in Science Translational Medicine, the study lays the early foundation for predicting which breast cancer patients may develop...
SANTA CLARA, Calif., Jan. 22, 2013 /PRNewswire/ -- NextBio today announced a translational research partnership with Emory University, Winship Cancer Institute and the Aflac Cancer Center aimed at using NextBio Clinical to interpret molecular and genomic data from children with medulloblastoma. The goal of the effort is to discover biomarkers that predict metastasis of the cancer in these young patients. Medulloblastoma is the most common brain tumor of childhood effecting around...
DETROIT, Jan. 17, 2013 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center has received a $25,000 grant through the Farrah Fawcett Foundation to establish the Farrah Fawcett Fund for Patient Assistance at Karmanos. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO) The fund will be administered by Karmanos' Social Work Department and will provide assistance to patients being treated at the center. The fund will help patients defray the costs of...
LA JOLLA, Calif. and ORLANDO, Fla., Jan. 15, 2013 /PRNewswire/ -- Sanford-Burnham Medical Research Institute Board of Directors (trustees) announced today that John C. Reed, M.D., Ph.D. has accepted the position of Head of Roche Pharma Research and Early Development and member of the Corporate Executive Committee. Kristiina Vuori, M.D., Ph.D., president of Sanford-Burnham, will assume all leadership responsibilities on an interim basis. "John has led Sanford-Burnham through a decade...
PORTSMOUTH, N.H., Jan. 8, 2013 /PRNewswire-iReach/ -- Harbor Consulting IP Services, Inc. ("HCIP") proudly announces that the company has established the Harbor Consulting IP Services, Inc. Charitable Fund ("the Fund") at the Dana-Farber Cancer Institute ("DFCI") in support of DFCI's ongoing cancer research, treatment, and patient care. Following HCIP's involvement with DFCI's Gene Display Wall and Vitals Bay sponsorship programs, creating the Fund extends HCIP's longstanding...
NEW YORK, Dec. 28, 2012 /PRNewswire/ -- Mediaplanet Publishing released its second 'Beating Cancer' report within the weekend edition of USA TODAY with Mark Herzlich, Giuliana Rancic, and Joe Torre. The publication is a 12-page advocacy campaign which will remain on newsstands through Saturday and Sunday. The glossy, full-color special section is spreading awareness about the recent advancements made in the cancer research industry, the cutting edge technology used today and the...
JACKSONVILLE and TAMPA, Fla., Dec. 20, 2012 /PRNewswire/ -- Florida Blue, Florida's Blue Cross and Blue Shield company, and Moffitt Cancer Center are proud to announce a new agreement creating an accountable care program specific to the treatment of cancer. (Logo: http://photos.prnewswire.com/prnh/20120904/MM67207LOGO ) The overall goals of accountable care arrangements are to improve individual patient care and overall health, as well as decrease medical costs. The accountable care...
Kim and Mark Reuss Chair Signature Event DETROIT, Dec. 13, 2012 /PRNewswire-USNewswire/ -- Join the celebration and help save lives by participating in the Barbara Ann Karmanos Cancer Institute's 2013 Annual Dinner, Saturday, April 20, at the General Motors' Detroit-Hamtramck Assembly Center in Detroit. Annual Dinner Chairs are Mark Reuss, president, General Motors North America, and his wife Kim. This signature event continues the great partnership between GM, the GM Foundation and...
Deal to develop MD Anderson discovery draws on expertise of Institute for Applied Cancer Science HOUSTON, Dec. 7, 2012 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center and GlaxoSmithKline (GSK) have signed a research collaboration and license agreement to develop new therapeutic antibodies that promote an immune system attack against cancer. Under terms of the agreement, MD Anderson grants GSK exclusive worldwide rights to develop and commercialize the...
